A

Abtx

Latest funding round: 2 M$

A

• City : Dijon
• Round : Seed
• Sector : Health

AbTx develops miniaturised antibody–drug conjugates to treat solid tumours. The company plans to license its technology and drug candidates to pharmaceutical and bioproduction companies.